BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34993017)

  • 1. Identification of high protein kinase CK2α in HPV(+) oropharyngeal squamous cell carcinoma and correlation with clinical outcomes.
    Trembley JH; Li B; Kren BT; Peltola J; Manivel J; Meyyappan D; Gravely A; Klein M; Ahmed K; Caicedo-Granados E
    PeerJ; 2021; 9():e12519. PubMed ID: 34993017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
    BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
    Head Neck; 2024 Apr; ():. PubMed ID: 38594829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk HPV detection by RNAscope in situ hybridization combined with Cdc2 protein expression by immunohistochemistry for prognosis of oropharyngeal squamous cell carcinoma.
    Yang JQ; Wu M; Han FY; Sun YM; Zhang L; Liu HX
    Int J Clin Exp Pathol; 2020; 13(8):2192-2200. PubMed ID: 32922620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
    Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
    J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Khwaja SS; Baker C; Haynes W; Spencer CR; Gay H; Thorstad W; Adkins DR; Nussenbaum B; Chernock RD; Lewis JS; Wang X
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1132-41. PubMed ID: 27209503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.
    Isaac A; Kostiuk M; Zhang H; Lindsay C; Makki F; O'Connell DA; Harris JR; Cote DW; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):5. PubMed ID: 28088212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections.
    Lifsics A; Cistjakovs M; Sokolovska L; Deksnis R; Murovska M; Groma V
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 16. CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma.
    Hewavisenti R; Ferguson A; Wang K; Jones D; Gebhardt T; Edwards J; Zhang M; Britton W; Yang J; Hong A; Palendira U
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32527931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection.
    Strojan P; Zadnik V; Šifrer R; Lanišnik B; Didanović V; Jereb S; Poljak M; Kocjan BJ; Gale N
    Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3805-14. PubMed ID: 25542247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Smoking, Comorbidity, Clinical Stage, and Treatment Intent With Socioeconomic Differences in Survival After Oropharyngeal Squamous Cell Carcinoma in Denmark.
    Olsen MH; Frederiksen K; Lassen P; Rotbøl C; Kjaer TK; Johansen J; Primdahl H; Andersen E; Kristensen CA; Andersen M; Farhadi M; Overgaard J; Dalton SO;
    JAMA Netw Open; 2022 Dec; 5(12):e2245510. PubMed ID: 36477477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.